艾媒咨询 | 2025年中国医用分子筛制氧行业发展白皮书

需求增长驱动医用分子筛制氧市场扩容，技术创新将推动行业向智能化、绿色化、高端化迈进。iiMedia Research（艾媒咨询）数据显示，2024年中国医用分子筛制氧机市场规模约4.25亿元，预计2029年将进一步攀升至7.06亿元。随着人口老龄化的加剧、公众健康意识的提高，以及医疗需求的增加，中国医用分子筛制氧机市场的规模在稳步扩大。同时，国家对医疗健康产业的重视程度不断提升，加之环保和新能源等领域的发展，医用分子筛制氧机在工业、医疗和家用等多个领域的应用正不断拓展。
Demand growth drives the expansion of the medical molecular sieve oxygen production market, and technological innovation will promote the industry to become intelligent, green and high-end. iiMedia Research data show that in 2024, the market size of China's medical molecular sieve oxygen generator is about 425 million yuan, and it is expected to further climb to 706 million yuan in 2029. With the increasing aging of the population, the improvement of public health awareness and the increase of medical demand, the scale of China's medical molecular sieve oxygen generator market is steadily expanding. At the same time, the state's attention to the medical and health industry continues to improve, coupled with the development of environmental protection and new energy and other fields, medical molecular sieve oxygen generator in industrial, medical and household applications are constantly expanding.